United States: Issue 112: Senate Health Care Reform Activity - Three Senators Derail Latest Effort At ACA Repeal

This is the one hundred and eleventh issue in our series of alerts for employers on selected topics on health care reform. (Click here to access our general Summary of Health Care Reform and other issues in this series.) This series of Health Care Reform Management Alerts is designed to provide an in-depth analysis of certain aspects of health care reform and how it will impact your employer-sponsored plans.

Seyfarth Synopsis: In a dramatic late night, as the clock ticked down on the GOP's legislative window to repeal the ACA, self-proclaimed "maverick" John McCain joined moderate Republicans Lisa Murkoswki and Susan Collins to narrowly defeat the latest ACA repeal effort, a so-called "skinny repeal" bill that was released just hours earlier. While we have written this several times before (each time more certain than the last), it now appears the GOP will move on from its failed ACA repeal efforts to focus on other legislative initiatives.

To understand last night's vote, it's important to take a few steps back and examine the series of events that were set in motion by the Senate's vote to proceed on consideration of the Better Care Reconciliation Act (BCRA) on Tuesday.

Tuesday, July 25th

  • With no margin for error, 50 Senate Republicans (plus Vice President Mike Pence, as the tie-breaker) voted to bring an ACA repeal bill to the Senate floor for debate. Majority Leader Mitch McConnell had been intentionally vague in the days leading up to the procedural vote on which bill would be under consideration, sensitive to the fact that every bill proposed thus far lacked the required votes.
  • To garner the support necessary to move the legislation, McConnell had to rely on Senator John McCain's dramatic last minute return to Washington; (he had been convalescing in Arizona following surgery to remove a blood clot and a brain cancer diagnosis).
  • Curiously, moments after casting the decisive vote to proceed, McCain took the floor to give a fiery speech blasting the process, expressing his lack of support for the BCRA, and pleading with Senators to return to "regular order" (passing legislation through a 60 vote majority rather than a simple majority).
  • Later that same night, the Senate proceeded to vote down a version of the BCRA. This version of the BCRA largely tracked the version we described in Alert 110, but with the addition of a $100 billion fund to help people transition from Medicaid. It appeared the bill needed 60 votes to pass, as it included provisions the Senate parliamentarian had ruled ineligible for passage with only 51 votes. Regardless, the bill fell short, garnering only 43 votes. Notably, given his earlier speech, McCain voted in favor of the bill.

Wednesday, July 26th

  • To fulfill a commitment necessary to obtain Senator Rand Paul's vote to proceed, the Senate voted on the so-called "Obamacare Repeal Reconciliation Act." This bill was cast as "repeal no replace", although it wasn't a full repeal as it only repealed those revenue/budget items eligible for passage with a simple majority. While it was clear from statements earlier in the week that this ORRA bill would not have the votes to pass, it was seen by some as an effort by Senator McConnell to force Senate Republicans to go on record voting against a straight repeal. Most of those same Senators had voted for a very similar bill in 2015, which was subsequently vetoed by President Obama ( see Alert 111).
  • The ORRA garnered only 45 votes in support, with McCain voting against the bill.

Thursday, July 27th

  • Early in the week, when it became evident that neither the BCRA nor the ORRA would have the votes to pass, there were whispers that the Senate was considering voting on a so-called "skinny repeal" bill. The idea was that the Senate would strip out all objectionable provisions of the earlier bills, focusing only on the lowest common denominators (those provisions most uniformly reviled by all Senate Republicans). The items rumored to be included were the individual mandate, the employer mandate, and the medical device tax.
  • By Thursday, even though the bill had not yet been released, this path became the only remaining viable option. Senate leadership started expressing optimism about the bill's chances as several of the usual holdouts suggested they might be willing to vote for this bill.
  • Shortly after close of business, Senators Lindsay Graham, Ron Johnson and John McCain held a surprise press conference, announcing they could not support skinny repeal unless they received assurances from Speaker of the House Paul Ryan that the House would not simply pass skinny repeal "as-is." Instead, the three wanted Ryan to guarantee the House would conference with the Senate and come up with a more robust repeal and replace plan that could garner the necessary votes in both chambers of Congress. In other words, the Senators wanted a guarantee that the bill they were about to vote in favor of would never become law. It remained unclear what this solution would be given the months of effort put into trying to make this work, but most viewed this as an effort to simply keep the ball rolling rather than throw in the towel.
  • After 8 pm Eastern Time, Speaker Ryan released a statement indicating the House was "willing" to go to conference on the bill. Graham, Johnson and McCain said this statement was insufficient and wanted further reassurances. A few hours later, following a call with Speaker Ryan, Graham and Johnson said they received the necessary assurances. However, McCain indicated he was still unsure and needed to consult with the Arizona governor.
  • Just before 11 pm Eastern Time (and only a few hours before the expected vote), the Senate finally released the text of the skinny repeal bill, labeled the "Health Care Freedom Act." At a high level, the bill included the following:

    • Repeal the individual mandate
    • Repeal the employer mandate (only through 2024 presumably because the Senate needed additional revenue  within a ten year window for the bill to be eligible for passage with 51 rather than 60 votes)
    • Postpone the ACA's medical device tax
    • Cut off federal funds for Planned Parenthood
    • Expand an ACA waiver program, giving states the option to roll back certain ACA benefit mandates
    • Expand HSA funding

Friday, July 28th

  • The CBO released a budget score for the HCFA, indicating it would result in 16 million fewer insured by 2026 and a 20% spike in premiums, but that it would save $135 billion over ten years. This last point was key because the bill had to save at least $133 billion (the savings in the House-passed AHCA) to pass with only 51 votes.
  • In the early hours of the morning, Vice President Mike Pence arrived on the Senate floor, indicating that leadership believed they would have the bare minimum - 50 votes - and that Pence would be the tie-breaker.
  • What played out next was quite dramatic. As expected, Senate leadership entered the vote without the support of Collins and Murkowski, and they were viewed as firm "no's", meaning the Republicans could lose no more votes.
  • It quickly became apparent that something was amiss as Mike Pence was seen standing by McCain feverishly lobbying him to shift his vote, to no avail. The roll call began, and the remaining Republican Senators fell in line, voting "yes". When they reached John McCain, he voted "no" with a thumbs down, followed by an audible gasp in the room. This was, perhaps, the most riveting moment involving the Maverick since Tom Cruise battled the Russians in Top Gun" (perhaps a fitting analogy on many fronts).
  • When it became clear the vote would fail, McConnell gave a few remarks expressing his extreme disappointment and blaming the Democrats.
  • Shortly thereafter, President Trump also tweeted "As I said from the beginning, let ObamaCare implode, then deal. Watch!"

What's Next?

Presumably, Congress will finally move on from ACA repeal and focus on tax reform and the remaining legislative backlog that had been building as both Chambers attempted to negotiate a workable health care approach. Things to watch for include:

  • Several moderate Republicans had expressed support for working in a bipartisan manner to shore up the individual market. Presumably, there would be sufficient bipartisan support to move forward legislation in this space. In fact, the Problem Solvers caucus, a bipartisan group of about 40 House members led by Tom Reed (R-N.Y.) and Josh Gottheimer (D-N.J.), has already been meeting about ways to fix the ACA. It's unclear whether President Trump would veto any such efforts.
  • The Trump Administration is now in the awkward position of implementing and enforcing a law that it abhors. This leaves many unanswered questions, including:

    • Will the IRS enforce the individual and employer mandates?
    • Will the Trump Administration continue to allocate funding for Marketplace subsidies (and will it continue  to do so only on a monthly basis or will it allocate long-term funding providing insurance carriers with the  reassurances necessary to commit to future participation)?
    • Will the regulatory agencies attempt to roll back or soften earlier guidance implementing the ACA?
    • Some Republicans have indicated they will continue their efforts to repeal the ACA. We would also expect that tax reform could include some targeted repeal of certain ACA taxes (such as the ACA's tax on high earners).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Diane V. Dygert
Similar Articles
Relevancy Powered by MondaqAI
Smith Gambrell & Russell LLP
Smith Gambrell & Russell LLP
Smith Gambrell & Russell LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Smith Gambrell & Russell LLP
Smith Gambrell & Russell LLP
Smith Gambrell & Russell LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions